Kenneth W. O'Keefe - 02 Dec 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
Director
Signature
By: /s/Paz Dizon, as attorney in fact For: Kenneth O'Keefe
Issuer symbol
JAZZ
Transactions as of
02 Dec 2025
Net transactions value
-$104,361
Form type
4
Filing time
04 Dec 2025, 17:48:04 UTC
Previous filing
11 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
O'Keefe Kenneth W Director 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND By: /s/Paz Dizon, as attorney in fact For: Kenneth O'Keefe 04 Dec 2025 0001397661

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Tax liability $104,361 -603 -2.3% $173.07 25,811 02 Dec 2025 Direct F1, F2
holding JAZZ Ordinary Shares 4,445 02 Dec 2025 by Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Kenneth W. O'Keefe is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Reflects the cancellation for no value of 2,258 RSU shares on December 1, 2025.
F3 Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.